Co-Diagnostics Debt to Equity Ratio 2017-2025 | CODX

Current and historical debt to equity ratio values for Co-Diagnostics (CODX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Co-Diagnostics debt/equity for the three months ending March 31, 2025 was 0.00.
Co-Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.01B $0.05B 0.15
2024-12-31 $0.01B $0.05B 0.18
2024-09-30 $0.01B $0.06B 0.14
2024-06-30 $0.01B $0.07B 0.12
2024-03-31 $0.01B $0.08B 0.11
2023-12-31 $0.01B $0.09B 0.11
2023-09-30 $0.01B $0.10B 0.09
2023-06-30 $0.01B $0.10B 0.09
2023-03-31 $0.01B $0.11B 0.06
2022-12-31 $0.01B $0.12B 0.08
2022-09-30 $0.01B $0.14B 0.10
2022-06-30 $0.02B $0.14B 0.11
2022-03-31 $0.02B $0.15B 0.16
2021-12-31 $0.03B $0.13B 0.19
2021-09-30 $0.01B $0.10B 0.05
2021-06-30 $0.01B $0.09B 0.06
2021-03-31 $0.01B $0.08B 0.06
2020-12-31 $0.01B $0.07B 0.07
2020-09-30 $0.00B $0.05B 0.04
2020-06-30 $0.00B $0.04B 0.09
2020-03-31 $0.00B $0.02B 0.07
2019-12-31 $0.00B $0.00B 0.28
2019-09-30 $0.00B $0.00B 0.14
2019-06-30 $0.00B $0.01B 0.11
2019-03-31 $0.00B $0.01B 0.10
2018-12-31 $0.00B $0.00B -2.47
2018-09-30 $0.00B $0.00B 20.30
2018-06-30 $0.00B $0.00B 0.58
2018-03-31 $0.00B $0.00B 0.30
2017-12-31 $0.00B $0.00B 0.21
2017-09-30 $0.00B $0.01B 0.17
2017-06-30 $0.01B $0.00B -1.11
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.009B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.850B 26.98
Elevance Health (ELV) United States $84.468B 10.90
CVS Health (CVS) United States $83.959B 10.44
Cencora (COR) United States $56.658B 19.71
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.415B 0.00
Labcorp Holdings (LH) United States $21.653B 17.56
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.432B 0.00
Solventum (SOLV) United States $12.967B 13.73
CochLear (CHEOY) Australia $12.826B 0.00
ICON (ICLR) Ireland $11.783B 10.95
Revvity (RVTY) United States $11.516B 19.82
Viatris (VTRS) United States $10.434B 3.58
Avantor (AVTR) United States $9.254B 13.45
HealthEquity (HQY) United States $8.991B 39.38
Medpace Holdings (MEDP) United States $8.943B 23.75
Sonic Healthcare (SKHHY) Australia $8.181B 0.00
Charles River Laboratories (CRL) United States $7.378B 14.46
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.305B 25.35
BrightSpring Health Services (BTSG) United States $3.975B 36.47
Sotera Health (SHC) United States $3.162B 17.97
Surgery Partners (SGRY) United States $2.782B 36.18
Alignment Healthcare (ALHC) United States $2.710B 0.00
Concentras Parent (CON) United States $2.631B 15.21
Organon (OGN) United States $2.600B 2.76
GeneDx Holdings (WGS) United States $2.537B 97.72
PACS (PACS) United States $1.951B 0.00
Ardent Health (ARDT) United States $1.877B 8.00
Premier (PINC) United States $1.799B 13.66
Progyny (PGNY) United States $1.792B 39.45
GoodRx Holdings (GDRX) United States $1.754B 35.07
Teladoc Health (TDOC) United States $1.328B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
Establishment Labs Holdings (ESTA) $1.084B 0.00
CareDx (CDNA) United States $1.064B 16.62
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.670B 10.14
LifeMD (LFMD) United States $0.584B 0.00
Embecta (EMBC) United States $0.580B 3.91
InnovAge Holding (INNV) United States $0.516B 0.00
Enhabit (EHAB) United States $0.476B 39.17
Auna S.A (AUNA) Luxembourg $0.464B 10.45
Sonida Senior Living (SNDA) United States $0.455B 0.00
Omada Health (OMDA) $0.452B 0.00
SBC Medicals (SBC) United States $0.442B 0.00
Performant Healthcare (PHLT) United States $0.301B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.258B 0.00
Beauty Health (SKIN) United States $0.242B 0.00
Oncology Institute (TOI) United States $0.192B 0.00
So-Young (SY) China $0.189B 0.00
DocGo (DCGO) United States $0.165B 27.00
Pheton Holdings (PTHL) China $0.113B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.095B 0.00
KindlyMD (NAKA) United States $0.085B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
ModivCare (MODV) United States $0.049B 0.00
Biodesix (BDSX) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00